Oncology & Cancer

94% of patients with cancer respond well to COVID-19 vaccines

In a U.S. and Swiss study, nearly all patients with cancer developed good immune response to the COVID-19 mRNA vaccines three to four weeks after receiving their second dose, but the fact that a small group of the patients ...

Diseases, Conditions, Syndromes

Combination therapy protects against advanced Marburg virus disease

A new study conducted at the Galveston National Laboratory at the The University of Texas Medical Branch at Galveston (UTMB) has shown substantial benefit to combining monoclonal antibodies and the antiviral remdesivir against ...

Diseases, Conditions, Syndromes

Germany to use corona meds that helped Trump

Germany will become the first European Union country to start using the same experimental antibodies treatment credited with helping Donald Trump recover from COVID-19, health minister Jens Spahn said Sunday.

Diseases, Conditions, Syndromes

US scientists developing nasal spray to prevent COVID-19

Scientists at the University of Pennsylvania and the biotech firm Regeneron are investigating whether technology developed for gene therapy can be used to make a nasal spray that will prevent infection with the new coronavirus.

Cardiology

A first-in-class antibody designed to prevent clotting

Researchers from Monash University have designed a novel antibody that inhibits one particular blood-borne protein to prevent clot formation, or thrombosis, without potential adverse side effects.

page 3 from 12